2005
DOI: 10.1021/mp050020d
|View full text |Cite
|
Sign up to set email alerts
|

Dendrimeric Micelles for Controlled Drug Release and Targeted Delivery

Abstract: This review highlights the developments in dendrimer-based micelles for drug delivery. Dendrimers, the perfectly branched monodisperse macromolecules, have certain structural advantages that make them attractive candidates as drug carriers for controlled release or targeted delivery. As polymeric micelle-based approaches precede the work in dendrimers, these are also discussed briefly. The review concludes with a perspective on possible applications of biaryl-based dendrimeric micelles that exhibit environment… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
181
0
3

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 221 publications
(187 citation statements)
references
References 51 publications
1
181
0
3
Order By: Relevance
“…Novel dendrimeric systems for applications as nano-scale drug-delivery systems include biaryl-based dendrimeric micelles that exhibit environment-dependent conformations [94], 'bow-tie' architectures that covalently connect a drug-loaded dendron to a PEGylated, solubilizing dendron [25] and hybrid dendrimer-based microcapsules that enable a dual release scheme [95]. In addition to serving as drug-delivery vectors, dendrimers can act as inherently-active antitumor, antiviral and antibacterial agents [96] and as permeability enhancers that can promote oral and transdermal drug delivery [93,97].…”
Section: Dendrimersmentioning
confidence: 99%
“…Novel dendrimeric systems for applications as nano-scale drug-delivery systems include biaryl-based dendrimeric micelles that exhibit environment-dependent conformations [94], 'bow-tie' architectures that covalently connect a drug-loaded dendron to a PEGylated, solubilizing dendron [25] and hybrid dendrimer-based microcapsules that enable a dual release scheme [95]. In addition to serving as drug-delivery vectors, dendrimers can act as inherently-active antitumor, antiviral and antibacterial agents [96] and as permeability enhancers that can promote oral and transdermal drug delivery [93,97].…”
Section: Dendrimersmentioning
confidence: 99%
“…It can be seen that the free PAMAM-G3 and PAMAM-G4 Figure 1A & 1B are spherical crystalline structures, with mean dimensions of 10 ± 2 nm [34][35][36][37][38][39][40][41], while testosterone-PAMAM, present average dimensions of 19 ± 3 nm ( Figures 1A, 1B, 1E & 1F) [28]. The results show that the steroid-PAMAM nanoparticles were larger in size than the free PAMAM due to testosterone encapsulation.…”
Section: Tem Images and The Morphology Of Testosteronepolymer Aggregatesmentioning
confidence: 93%
“…Synthetic polymers capable of specific recognition have found applications in a variety of fields, from chemical sensing (Rimmel and Bäuelre, 1999;Scheib and Bäuerle, 1999;McQuade et al, 2000) to separations (Daniel et al, 1989;Xinjian et al, 2007;Priego-Capote et al, 2008) and drug delivery (Yasugi et al, 1999;Ambade et al, 2005;Lim Soo et al, 2005;Paleos et al, 2006;Li and Wallace, 2008). The area of polymer therapeutics, in particular, has evolved to include polymer-drug and polymer-protein conjugates, molecularly imprinted polymers (Yang and Li, 2005;Huiqi et al, 2006;Ye and Mosbach, 2008;Meng et al, 2009), and polymeric micelles containing covalently bound drugs (Kolhe et al, 2004;Patri et al, 2005;Khandare and Minko, 2006;Vicent and Duncan, 2006;Boyer et al, 2007;Fox et al, 2009;Krakoviˇcová et al, 2009;Prabaharan et al, 2009).…”
Section: Introductionmentioning
confidence: 99%